Diarrhea-predominant Irritable Bowel Syndrome
3 competing products in clinical development for Diarrhea-predominant Irritable Bowel Syndrome.
Pipeline by Phase
Pre-clinical1
Phase 32
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| YM060 + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| YM060 | Astellas Pharma | Phase 3 | Completed | 40 |
| Ramosetron | Astellas Pharma | Pre-clinical | Completed | 26 |